To add to that taken from @Sam_123 post https://hotcopper.com.au/posts/49657665/single
SI makes reference to this exact possibility.
It’s these data where Mesoblast now sees a potential path ahead. Itescu further told investors in Monday’s call that rexlemestrocel-L could prove a complementary medicine to drugs that reduce hospitalizations but don’t reduce mortality.He also said in previous meetings with the FDA that the agency has made clear it is focusing on mortality, despite hospitalization serving as primary.
- Forums
- ASX - By Stock
- MSB
- Ann: Trading halt
Ann: Trading halt, page-638
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.324B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $4.629M | 3.927M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 29476 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 106203 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 22446 | 1.160 |
27 | 44419 | 1.155 |
17 | 154046 | 1.150 |
14 | 206116 | 1.145 |
9 | 199738 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 111996 | 12 |
1.170 | 64280 | 10 |
1.175 | 72571 | 10 |
1.180 | 74516 | 7 |
1.185 | 36343 | 4 |
Last trade - 14.37pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online